Finished product reference
Baricitinib
Tablet · Oral · 4 mg
- List code
- 52845
- Pharmacologic class
- Janus Kinase Inhibitor
What it is and how it works
Mechanism class: Janus Kinase Inhibitors
Source: Baricitinib (Baricitinib) — US FDA prescribing information, 2022-05-10, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.